Topical Rx therapies alone may not provide adequate control for many
patients with moderate-to-severe atopic dermatitis (AD)
The following may indicate that your patient is appropriate for DUPIXENT:
- Have tried a variety of topical prescription therapies for moderate-to-severe atopic dermatitis and are still uncontrolled1
- Suffer from inadequate control of pruritus1
- Have moderate-to-severe erythema and moderate-to-severe papulation/infiltration (IGA 3 or 4)2
- Have ≥10% of their body covered with lesions3
- Have disease that may involve problem areas, such as the face, hands, and feet3
- Initially had itch and
hyperpigmentation on arms, back,
and chest - Saw multiple providers who each
prescribed medium-potency TCS - Consulted a specialist after 7 years
- Completed 3 rounds of high-potency
TCS in past year - Hyperpigmented papules, patches,
and plaques across back and arms - Frustrated by frequent TCS
application, describing it as
“cumbersome” and “uncomfortable”
Real image of uncontrolled moderate-to-severe atopic dermatitis.
Story inspired by people who suffer from atopic dermatitis.
- Legs and arms affected by itch
and lesions - PCP prescribed medium-potency TCS
- Consulted specialist after 2 years of
inadequate control
- Almost daily application of medium-
potency TCS for past 6 months - Itchy every day and night; patient
says, “it's just my normal” - Enjoys sports, but the uniforms
exacerbate her itch - Fidgety and distracted during
office visits
Real image of uncontrolled moderate-to-severe atopic dermatitis.
Story inspired by people who suffer from atopic dermatitis.
- Dry patches and lichenification
developed on arms and torso, along
with itch - PCP prescribed medium-potency
TCS, which failed to fully resolve
lesions - Consulted specialist after 1 year
- Primarily using high-potency TCS for
the past 6 months - Stepping down to medium-potency
TCS hasn't been successful - Always wears long sleeves and
pants to cover up, but is “used to it”
Real image of uncontrolled moderate-to-severe atopic dermatitis.
Story inspired by people who suffer from atopic dermatitis.
For your patients aged 6+ months with moderate-to-severe AD
uncontrolled with topical Rx therapy, ask yourself:
If you answer “Yes” to either of these questions,
THEY MAY BE DU FOR DUPIXENT
IGA, Investigator’s Global Assessment; PCP, primary care physician; TCS, topical corticosteroids.
Real Providers share real patient stories